Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 780,567 | 631,449 | 566,767 | 463,933 | 276,868 |
| Cost of Goods | 317,310 | 254,105 | 240,598 | 254,445 | 126,251 |
| Gross Profit | 463,257 | 377,344 | 326,169 | 209,488 | 150,617 |
| Operating Expenses | 283,931 | 207,554 | 159,806 | 176,614 | 133,240 |
| Operating Income | 179,636 | 169,895 | 166,961 | 33,319 | 17,628 |
| Interest Expense | 82,312 | 73,974 | 83,339 | 63,213 | 21,014 |
| Other Income | -4,705 | 2,647 | -7,889 | 1,047 | 12 |
| Pre-tax Income | 92,619 | 98,568 | 75,733 | -28,847 | -3,374 |
| Income Tax | 29,749 | 29,378 | 27,578 | -3,845 | -74,891 |
| Net Income Continuous | 62,870 | 69,190 | 48,155 | -25,002 | 71,517 |
| Net Income | $62,870 | $69,190 | $48,155 | $-25,002 | $71,517 |
| EPS Basic Total Ops | 1.98 | 2.14 | 1.43 | -0.74 | 2.05 |
| EPS Basic Continuous Ops | 1.98 | 2.14 | 1.43 | -0.74 | 2.05 |
| EPS Diluted Total Ops | 1.73 | 1.86 | 1.29 | -0.74 | 1.86 |
| EPS Diluted Continuous Ops | 1.58 | 1.71 | 1.15 | -0.74 | 1.74 |
| EPS Diluted Before Non-Recurring Items | N/A | 5.86 | 4.99 | 3.53 | 0.34 |
| EBITDA(a) | $404,638 | $337,027 | $314,982 | $172,258 | $86,545 |